---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-071516"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:06:16.387220+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# RxSight reports Q4 revenue down 19% YoY; 2025 net loss $(38.9M); issues weak 2026 guidance

## Summary
- Q4 2025 revenue $32.6M (-19% YoY); LAL revenue -1%, LDD revenue -72%.
- FY 2025 revenue $134.5M (-4% YoY); net loss $(38.9M) vs $(27.5M) in 2024.
- LAL unit sales 109,615 (+12% YoY); LDD installed base 1,134 units; procedures >300,000 since launch.
- FY 2026 guidance: revenue $120-135M (down YoY); gross margin 70-72%; op-ex $150-160M.
- Adjusted net loss per share $(0.18) in FY 2025 vs $(0.07) in FY 2024; cash $228.1M.

## SEC filing metadata
- accession: 0001193125-26-071516
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000119312526071516/0001193125-26-071516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000119312526071516/rxst-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-071516
- JSON: https://secwatch.observer/filing/0001193125-26-071516.json
- Plain text: https://secwatch.observer/filing/0001193125-26-071516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.